Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
PHASE1
This pilot phase I trial studies the side effects and best way to give siro...
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
PHASE1
RATIONALE: Drugs used in chemotherapy, such as gemcitabine hydrochloride an...
Status
Completed
Location
Leeds Cancer Centre at St. James's University Hospital